413 related articles for article (PubMed ID: 30797879)
1. Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles.
Ahmad A; Khan JM; Haque S
Biochimie; 2019 May; 160():61-75. PubMed ID: 30797879
[TBL] [Abstract][Full Text] [Related]
2. Endosomal escape pathways for delivery of biologicals.
Varkouhi AK; Scholte M; Storm G; Haisma HJ
J Control Release; 2011 May; 151(3):220-8. PubMed ID: 21078351
[TBL] [Abstract][Full Text] [Related]
3. Controlling endosomal escape using nanoparticle composition: current progress and future perspectives.
Cupic KI; Rennick JJ; Johnston AP; Such GK
Nanomedicine (Lond); 2019 Jan; 14(2):215-223. PubMed ID: 30511881
[TBL] [Abstract][Full Text] [Related]
4. Metal-Phenolic Coatings as a Platform to Trigger Endosomal Escape of Nanoparticles.
Chen J; Li J; Zhou J; Lin Z; Cavalieri F; Czuba-Wojnilowicz E; Hu Y; Glab A; Ju Y; Richardson JJ; Caruso F
ACS Nano; 2019 Oct; 13(10):11653-11664. PubMed ID: 31573181
[TBL] [Abstract][Full Text] [Related]
5. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
[TBL] [Abstract][Full Text] [Related]
6. Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors.
Degors IMS; Wang C; Rehman ZU; Zuhorn IS
Acc Chem Res; 2019 Jul; 52(7):1750-1760. PubMed ID: 31243966
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
[TBL] [Abstract][Full Text] [Related]
8. Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.
Selby LI; Cortez-Jugo CM; Such GK; Johnston APR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28160452
[TBL] [Abstract][Full Text] [Related]
9. Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents.
Brock DJ; Kondow-McConaghy HM; Hager EC; Pellois JP
Bioconjug Chem; 2019 Feb; 30(2):293-304. PubMed ID: 30462487
[TBL] [Abstract][Full Text] [Related]
10. Endosomal Escape of Bioactives Deployed via Nanocarriers: Insights Into the Design of Polymeric Micelles.
Butt AM; Abdullah N; Rani NNIM; Ahmad N; Amin MCIM
Pharm Res; 2022 Jun; 39(6):1047-1064. PubMed ID: 35619043
[TBL] [Abstract][Full Text] [Related]
11. The proton sponge hypothesis: Fable or fact?
Vermeulen LMP; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Biopharm; 2018 Aug; 129():184-190. PubMed ID: 29859281
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal monitoring endocytic and cytosolic pH gradients with endosomal escaping pH-responsive micellar nanocarriers.
Hu J; Liu G; Wang C; Liu T; Zhang G; Liu S
Biomacromolecules; 2014 Nov; 15(11):4293-301. PubMed ID: 25317967
[TBL] [Abstract][Full Text] [Related]
14. The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery.
Smith SA; Selby LI; Johnston APR; Such GK
Bioconjug Chem; 2019 Feb; 30(2):263-272. PubMed ID: 30452233
[TBL] [Abstract][Full Text] [Related]
15. Designing Mesoporous Silica Nanoparticles to Overcome Biological Barriers by Incorporating Targeting and Endosomal Escape.
Gisbert-Garzarán M; Lozano D; Matsumoto K; Komatsu A; Manzano M; Tamanoi F; Vallet-Regí M
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9656-9666. PubMed ID: 33596035
[TBL] [Abstract][Full Text] [Related]
16. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.
El-Sayed A; Futaki S; Harashima H
AAPS J; 2009 Mar; 11(1):13-22. PubMed ID: 19125334
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of Endosomolytic Peptides with Varying Disruption Mechanisms into EGFR-Targeted Protein Conjugates: The Effect on Intracellular Protein Delivery and EGFR Specificity in Breast Cancer Cells.
Lieser RM; Li Q; Chen W; Sullivan MO
Mol Pharm; 2022 Feb; 19(2):661-673. PubMed ID: 35040326
[TBL] [Abstract][Full Text] [Related]
18. Identification and optimization of tunable endosomal escape parameters for enhanced efficacy in peptide-targeted prodrug-loaded nanoparticles.
Mejia F; Khan S; Omstead DT; Minetos C; Bilgicer B
Nanoscale; 2022 Jan; 14(4):1226-1240. PubMed ID: 34993530
[TBL] [Abstract][Full Text] [Related]
19. Polycation gene delivery systems: escape from endosomes to cytosol.
Cho YW; Kim JD; Park K
J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
[TBL] [Abstract][Full Text] [Related]
20. Novel endosomolytic peptides for enhancing gene delivery in nanoparticles.
Ahmad A; Ranjan S; Zhang W; Zou J; Pyykkö I; Kinnunen PK
Biochim Biophys Acta; 2015 Feb; 1848(2):544-53. PubMed ID: 25445677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
